Virpax Pharmaceuticals Inc (VRPX)
0.80
+0.02
(+2.56%)
USD |
NASDAQ |
May 16, 16:00
0.8398
+0.04
(+4.98%)
After-Hours: 06:47
Virpax Pharmaceuticals Total Assets (Quarterly): 9.628M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 9.628M |
| September 30, 2023 | 13.04M |
| June 30, 2023 | 15.95M |
| March 31, 2023 | 18.49M |
| December 31, 2022 | 19.67M |
| September 30, 2022 | 23.64M |
| June 30, 2022 | 29.40M |
| March 31, 2022 | 34.75M |
| Date | Value |
|---|---|
| December 31, 2021 | 39.57M |
| September 30, 2021 | 43.27M |
| June 30, 2021 | 11.39M |
| March 31, 2021 | 13.22M |
| December 31, 2020 | 0.4654M |
| September 30, 2020 | 0.451M |
| December 31, 2019 | 0.0467M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
0.0467M
Minimum
Dec 2019
43.27M
Maximum
Sep 2021
18.20M
Average
15.95M
Median
Jun 2023
Total Assets (Quarterly) Benchmarks
| Sorrento Therapeutics Inc | 456.69M |
| Scilex Holding Co | 91.24M |
| Coya Therapeutics Inc | 37.39M |
| CEL-SCI Corp | 28.71M |
| AIM ImmunoTech Inc | 19.38M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 7.694M |
| Shareholders Equity (Quarterly) | 1.934M |